<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-64434</identifier>
<setSpec>1137-6627</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">Mesenteric panniculitis can be considered as a nevolved state of a mesenteric disease, with a first phase of mesenteric lipodys trophy without inflammatory signs, followed by a second phase of panniculitis, ending in fibrosis, at which point it is denominated retractile mesentiritis, which principally affects males over the age of 50. It&#146;s a etiology is unknown, with a description made of different associated factors, and its clinical presentation is variable, depending on the stage of the disease. The image test indicated for its diagnosis is the TAC, while an histopathological study provides the definitive diagnosis. There are different medicines and therapeutic guidelines, although studies establishing the ideal treatment are lacking. We present the case of a patient diagnosed with mesenteric panniculitis who evolved favourably followed treatment with cyclophosphamide associated with corticoids (AU)</dc:description>
<dc:creator>Artondo, M. T</dc:creator>
<dc:creator>García de Eulate, I</dc:creator>
<dc:creator>Rubio, T</dc:creator>
<dc:creator>Cires, M</dc:creator>
<dc:creator>González, C. I</dc:creator>
<dc:creator>Jiménez, F. J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La paniculitis mesentérica puede ser considerada como un estadio evolutivo de una enfermedad mesentérica, con una primera fase de lipodistrofia mesentérica sin signos inflamatorios, seguida de una segunda fase de paniculitis, para finalizar en fibrosis, denominándose entonces mesenteritis retráctil, que afecta principalmente a varones con más de 50 años. La etiología es desconocida, habiéndose descrito diferentes factores asociados, y la presentación clínica es variable, en función del estadio de la enfermedad. Para su diagnóstico la TAC es la prueba de imagen indicada, siendo el estudio histopatológico el que arrojará el diagnóstico definitivo. Existen diferentes fármacos y pautas terapéuticas, si bien se carecen de estudios donde se establezca el tratamiento idóneo. Presentamos el caso de un paciente diagnosticado de paniculitis mesentérica que ha evolucionado satisfactoriamente tras haber sido tratado con ciclofosfamida asociada a corticoides (AU)</dc:description>
<dc:source>An Sist Sanit Navar;31(1): 81-85, ene.-abr. 2008. ilus</dc:source>
<dc:identifier>ibc-64434</dc:identifier>
<dc:subject>^d8235^s22016</dc:subject>
<dc:subject>^d24339^s22045</dc:subject>
<dc:subject>^d23438^s22045</dc:subject>
<dc:subject>^d8235^s22012</dc:subject>
<dc:subject>^d308^s22073</dc:subject>
<dc:subject>^d22921^s22045</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d23794^s29166</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d3540^s22073</dc:subject>
<dc:subject>^d23794^s22067</dc:subject>
<dc:subject>^d23794^s22016</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:type>article</dc:type>
<dc:date>200804</dc:date>
</metadata>
</record>
</ibecs-document>
